Related Experiment Video
Updated: Jul 19, 2026

An Immature Murine Model of Reversible Unilateral Ureteral Obstruction
Published on: April 4, 2025
Endoscopic subureteral injection treatment with calcium hydroxylapatite in primary vesicoureteral reflux
Bilal Eryildirim1, Fatih Tarhan, Uğur Kuyumcuoğlu
1Dr Lütfi Kirdar Kartal Training and Research Hospital, 1, Urology Clinic, Istanbul, Turkey.
Insights
Subureteral injection of calcium hydroxylapatite effectively treats primary vesicoureteral reflux (VUR) in children. This minimally invasive procedure offers a high success rate for resolving VUR, improving patient outcomes.
Area of Science:
- Pediatric Urology
- Minimally Invasive Surgery
Background:
- Primary vesicoureteral reflux (VUR) affects numerous children.
- Evaluating novel treatments for VUR is crucial for improving outcomes.
Purpose of the Study:
- To assess the efficacy of calcium hydroxylapatite subureteral injection for treating primary VUR in pediatric patients.
- To determine the success rate and safety of this minimally invasive VUR treatment.
Main Methods:
- A cohort of 25 children with primary VUR underwent subureteral injection of calcium hydroxylapatite.
- The study included 39 ureteral units with VUR grades II, III, and IV.
- Treatment involved endoscopic injection of calcium hydroxylapatite.
Main Results:
- A single injection resolved reflux in 59.0% of ureteral units.
- A second injection was successful in an additional 12.8% of units.
- The overall success rate for VUR treatment with calcium hydroxylapatite was 71.8%.
Conclusions:
- Endoscopic subureteral injection of calcium hydroxylapatite is an effective treatment for primary VUR in children.
- The procedure is safe and minimally invasive.
- This technique offers a promising option for managing low-grade VUR.
Introduction:
In this study, we aimed to evaluate efficiency of subureteral injection of calcium hydroxylapatite treatment for primary vesicoureteral reflux (VUR).
Materials And Methods:
A total of 25 children (mean age 6.9 +/- 2.7 years) underwent subureteral injection of calcium hydroxylapatite for primary VUR. Reflux was present in 39 ureteral units that were unilateral in 11 cases and bilateral in 14 cases. According to "International Reflux Classification"; grade II in 12 (30.8%), grade III in 18 (46.2%) and grade IV in 9 (23.1%) ureteral units were found.
Results:
The refluxes were resolved in 23 (59.0%) ureteral units after a single injection and 5 ureteral units (12.8%) after a second injection. Overall success rate of reflux treatment with calcium hydroxylapatite was 71.8% in all ureteral units.
Conclusion:
Endoscopic subureteral injection of calcium hydroxylapatite in children with primary low-grade VUR appears to be an effective, safe and minimally invasive technique.
Related Concept Videos
Urinary Tract Calculi III: Medical Management
Imaging Studies V: Intravenous Urography and Retrograde Pyelography
Urinary Tract Calculi VI: Surgical Management
Urinary Tract Calculi IV: Nutrition Therapy and Prevention
Urinary Tract Calculi V: Nursing Management
Urinary Tract Calculi I: Introduction